Kyushu Hematology Organization for Treatment Study Group : Phase I study of thecombination of irinotecan hydrochloride, carboplatin, and dexamethasone for the treatment of relapsed or refractory malignant lymphoma.

Bibliographic Information

Title
Kyushu Hematology Organization for Treatment Study Group : Phase I study of thecombination of irinotecan hydrochloride, carboplatin, and dexamethasone for the treatment of relapsed or refractory malignant lymphoma.
Author
Suzumiya J, Suzushima H, Maeda K, Okamura S, Utsunomiya A, Shibuya T, Tamura K

Journal

Related Projects

See more

Details 詳細情報について

  • CRID
    1010282256791332509
  • Article Type
    journal article
  • Data Source
    • KAKEN

Report a problem

Back to top